Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:1585-1589
Published online before print March 15, 2007, doi: 10.1161/STROKEAHA.106.475897
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/5/1585    most recent
STROKEAHA.106.475897v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kollmar, R.
Right arrow Articles by Schwab, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kollmar, R.
Right arrow Articles by Schwab, S.
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors

(Stroke. 2007;38:1585.)
© 2007 American Heart Association, Inc.


Original Contributions

Different Degrees of Hypothermia After Experimental Stroke

Short- and Long-Term Outcome

Rainer Kollmar, MD; Tobias Blank; Junliang L. Han, MD; Dimitrios Georgiadis, MD Stefan Schwab, MD, PhD

From the Department of Neurology (R.K., S.S.), University of Erlangen, Erlangen, Germany; the Department of Neurology (R.K., T.B., J.L.H., S.S.), University of Heidelberg, Heidelberg, Germany; and the Department of Neurology (D.G.), University of Zurich, Zurich, Switzerland.

Correspondence to R. Kollmar, MD, Department of Neurology, University of Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany. E-mail rainer.kollmar{at}neuro.imed.uni-erlangen.de

Background and Purpose— The neuroprotective role of mild therapeutic hypothermia was established in animal models of cerebral ischemia. Still, several issues, including optimal target temperature, remain unclear. The optimal depth of hypothermia in a rat model of focal cerebral ischemia was investigated.

Methods— Eighty-four male Wistar rats (n=84) were subjected to filament occlusion of the middle cerebral artery for 90 minutes. Sixty animals were equally split into 6 groups kept at core temperatures of 37°C, 36°C, 35°C, 34°C, 33°C, and 32°C over a period of 4 hours starting 90 minutes after middle cerebral artery occlusion. Twenty-four hours later, after performing a neuroscore, animals were killed and brains examined for infarct size, edema, and invasion of leukocytes. In the second part, 24 animals (8 per group) were kept at 33°C, 34°C, and 37°C for 4 hours, allowed to survive for 5 days, and underwent additional investigation of transferase dUTP nick-end labeling.

Results— In the first part, one animal in each treatment group and 2 animals in group 37°C died. The infarct size and edema were smaller for 34°C and 33°C compared with all other groups (P<0.05) over 24 hours. These animals also had better functional outcome (P<0.05) with an advantage for 34°C versus 33°C (P<0.05). Leukocyte count was lower for 34°C and 33°C as compared with the 37°C group. Similar results were obtained in the second part of the study with an advantage for 34°C versus 33°C.

Conclusion— Our results suggest that the optimal depth of therapeutic hypothermia in temporary middle cerebral artery occlusion is 34°C.


Key Words: brain edema • hypothermia • rat • stroke




This article has been cited by other articles:


Home page
StrokeHome page
D. I. Sessler
Defeating Normal Thermoregulatory Defenses: Induction of Therapeutic Hypothermia
Stroke, November 1, 2009; 40(11): e614 - e621.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
B. P. Meloni, F. L. Mastaglia, and N. W. Knuckey
Review: Therapeutic applications of hypothermia in cerebral ischaemia
Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 75 - 98.
[Abstract] [PDF]


Home page
FASEB J.Home page
H. N. David, B. Haelewyn, C. Rouillon, M. Lecoq, L. Chazalviel, G. Apiou, J.-J. Risso, M. Lemaire, and J. H. Abraini
Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia
FASEB J, April 1, 2008; 22(4): 1275 - 1286.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. J. Spencer, M. A. Galic, M. Tsutsui, Q. J. Pittman, and A. Mouihate
Effects of Global Cerebral Ischemia in the Pregnant Rat
Stroke, March 1, 2008; 39(3): 975 - 982.
[Abstract] [Full Text] [PDF]